COSM
Cosmos Health Inc. (COSM) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
Low R&D intensity versus diversified consumer peers suggests limited environmental innovation capacity, though the metric alone does not indicate materially worse operational footprint.
Negative net debt to EBITDA implies balance-sheet flexibility relative to leveraged peers, which can support funding for efficiency initiatives if management prioritizes them.
Gross margin near 10% indicates a constrained cost base, which can limit near-term capital available for environmental upgrades versus better-capitalized peers.
No disclosed emissions, energy, or waste metrics were provided, so relative environmental positioning remains difficult to verify against peers and is assessed conservatively.
Social
Stock-based compensation at roughly 2.3% of revenue is modest, suggesting less dilution-related employee alignment risk than peers with heavier equity pay structures.
Limited R&D spend relative to revenue can constrain product and service differentiation, which may indirectly weaken workforce skill development versus more innovation-intensive peers.
Gross profitability remains thin, which can pressure staffing, training, and service investment capacity compared with peers that sustain stronger operating buffers.
No workforce, safety, turnover, or customer-impact disclosures were provided, so the social assessment relies on limited financial proxies and remains mid-range.
Governance
Debt-to-equity of 0.77 indicates moderate leverage, which is less conservative than low-debt peers but not severe enough to signal a structural governance weakness.
Negative net debt to EBITDA suggests manageable leverage dynamics versus more indebted peers, supporting a somewhat stronger governance risk profile.
Stock-based compensation near 2.3% of revenue is not excessive, implying comparatively restrained dilution risk and more disciplined capital allocation than many peers.
Absent board, audit, ownership, and controversy disclosures, governance quality cannot be fully benchmarked, so the score reflects only a modest relative advantage.
Overall Score
COSM appears broadly middle-of-pack on ESG relative to peers, with limited disclosed data and only modest balance-sheet and compensation discipline advantages.
Score Driver: Sparse ESG Disclosure Prevents Evidence Of A Clear Peer-Leading Position Across Material Environmental, Social, And Governance Factors.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Cosmos Health Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
